Related Experiment Video
Updated: Mar 14, 2026

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats
Published on: November 6, 2018
Do specific NMDA receptor subunits act as gateways for addictive behaviors?
1Alcohol and Addiction Research Group, Department of Neurology, University of California at San Francisco, San Francisco, CA, USA.
NMDA receptors (NMDARs) are crucial for learning and memory, and their activity drives alcohol and drug addiction. Targeting NMDARs, especially GluN2B subunits, may offer new addiction treatments.
Area of Science:
- Neuroscience
- Molecular Biology
- Addiction Research
Background:
- Addiction is a significant societal issue driven by complex molecular mechanisms.
- NMDA receptors (NMDARs) are implicated in synaptic plasticity, learning, and memory formation.
Purpose of the Study:
- To review the role of NMDAR activity in promoting drug and alcohol addiction.
- To highlight the significance of GluN2B subunits and non-canonical NMDARs in addictive behaviors.
Main Methods:
- Review of existing literature on NMDARs and addiction.
- Focus on molecular mechanisms, synaptic plasticity, and calcium signaling.
- Examination of specific NMDAR subunits and cofactors.
Main Results:
- NMDARs, activated by depolarization, exhibit calcium permeability and induce long-term molecular changes.
- NMDAR-mediated plasticity can create memory traces linking drug-related stimuli to behaviors.
- GluN2B subunits are identified as potential key regulators of addictive behaviors.
Conclusions:
- NMDAR activity plays a critical role in the development and maintenance of addiction.
- Understanding NMDAR function, including non-canonical subunits, is vital for addiction research.
- Targeting specific NMDAR components may offer novel therapeutic strategies for addiction.
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
CNS Depressants: Alcohol and Nicotine
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Opioid Receptors: Overview
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Drugs Affecting Neurotransmitter Release or Uptake

